Chairman & CEO of Edwards Lifesciences Corp (EW, Financial) Michael A Mussallem sold 49,100 shares of EW on 08/11/2016 at an average price of $114.01 a share. The total sale was $5.6 million.
Edwards Lifesciences Corp technologies that treat structural heart disease and critically ill patients. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards Lifesciences Corp has a market cap of $24.18 billion; its shares were traded at around $113.60 with a P/E ratio of 46.90 and P/S ratio of 9.04. Edwards Lifesciences Corp had an annual average EBITDA growth of 19.10% over the past 10 years. GuruFocus rated Edwards Lifesciences Corp the business predictability rank of 4-star.
CEO Recent Trades:
- Chairman & CEO Michael A Mussallem sold 49,100 shares of EW stock on 08/11/2016 at the average price of $114.01. The price of the stock has decreased by 0.36% since.
- Chairman & CEO Michael A Mussallem sold 49,100 shares of EW stock on 07/28/2016 at the average price of $113.31. The price of the stock has increased by 0.26% since.
Directors and Officers Recent Trades:
- Director John T Cardis sold 5,000 shares of EW stock on 08/10/2016 at the average price of $113.21. The price of the stock has increased by 0.34% since.
- CVP, Europe Patrick B Verguet sold 10,000 shares of EW stock on 08/09/2016 at the average price of $113.48. The price of the stock has increased by 0.11% since.
- CVP, Japan & Intercontinental Huimin Wang sold 13,650 shares of EW stock on 08/05/2016 at the average price of $113.03. The price of the stock has increased by 0.5% since.
- CVP, THV Replacement Larry L Wood sold 13,257 shares of EW stock on 08/01/2016 at the average price of $114.24. The price of the stock has decreased by 0.56% since.
- Director Schack Wesley W Von sold 6,000 shares of EW stock on 08/01/2016 at the average price of $113.98. The price of the stock has decreased by 0.33% since.
For the complete insider trading history of EW, click here
.
